Pfizer (PFE) Tops Q1 EPS by 24c; offers guidance
Tweet
Share
E-mail
Get Alerts PFE Hot Sheet
Price: $24.04 --0%
EPS Growth %: -12.8%
Financial Fact:
Net income attributable to Pfizer Inc.: 1.32B
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -12.8%
Financial Fact:
Net income attributable to Pfizer Inc.: 1.32B
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Pfizer (NYSE: PFE) reported Q1 EPS of $0.92, $0.24 better than the analyst estimate of $0.68. Revenue for the quarter came in at $13.72 billion versus the consensus estimate of $14.09 billion.
GUIDANCE:
Pfizer sees FY2025 EPS of $2.80-$3.00, versus the consensus of $2.95. Pfizer sees FY2025 revenue of $61-64 billion, versus the consensus of $62.92 billion.
For earnings history and earnings-related data on Pfizer (PFE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BlackBerry (BB) Tops Q1 EPS by 1c, Offers Guidance
- Flash Sports & Media plans Zimbabwe T20 cricket league for 2026
- Micron Technology (MU) Tops Q3 EPS by $4.62, Guidance Beats
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
